January 13th, 2021‘Long COVID’ – a version of COVID-19 that results in continued illness of a significant number of people for many months after the initial disease has waned –...
Pfizer Inc and BioNTech SE have announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies...
December 9th, 2020Survivors from a wide range of cancers are more likely than people in the general population to be hospitalised or die from seasonal influenza even several years after...
November 11th, 2020People whose treatment for cancer is delayed by even one month have 6% to 13% higher risk of dying – a risk that keeps rising the longer treatment does not begin –...
October 28th, 2020Use of preventive antimalarial treatments reduces by half the number of malaria infections, among schoolchildren, as well as reducing anaemia, according to a...
The International Partnership for Microbicides (IPM) has welcomed a positive opinion from the European Medicines Agency (EMA) on the dapivirine vaginal ring for use by...Coronavirus
Experts have cautiously welcomed the results of a small trial of a coronavirus treatment that has dramatically reduced the odds of hospitalised patients progressing to...
June 24th, 2020In this 21-nation, population-based cohort study, adults with depressive symptoms were associated with having increased risk of cardiovascular disease (CVD) and...
People under 20 years of age are approximately half as susceptible to COVID-19 as are people 20 years of age and older, according to a modelling paper. The study also...Weekly Roundup
World Health Organisation experts and a range of other scientists have found no evidence to support an assertion by a high-profile Italian doctor that the coronavirus...
